In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PEOPLE - ResMed makes appointment:

This article was originally published in Clinica

Executive Summary

Kieran Gallahue is being promoted to CEO of ResMed, a Poway, California-based specialist in devices for sleep apnoea and other respiratory conditions, effective January 1 2008. Mr Gallahue, currently president and COO of the ResMed Global division, will replace company founder Dr Peter Farrell, who will remain as executive chairman of the board until June 30, becoming non-executive chairman thereafter. Mr Gallahue joined as president and COO of the Americas division in January 2003.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT048588

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel